Dergiler / Cardiovascular surgery and interventions / 2022 / Cilt: 9 - Sayı: 2

Single center experience with percutaneous peripheral atherectomy with the use of C-arm scopy for the treatment of lower extremity peripheral artery disease İbrahim Erdinç

Sayfa
111–120
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The perioperative and mid-term follow-up results of our study indicate that atherectomy and drug-coated balloon angioplasty may safely be performed by C-arm scopy with favorable outcomes.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study aimed to present our results of endovascular procedures including balloon angioplasty combined with or without atherectomy for the treatment of iliofemoral and distal lesions with the use of a C-arm scopy.
📊
Temel Bulgular & Veri:Patients and methods: The retrospective study was conducted on 153 patients (100 males, 53 females; mean age: 60.2±2.1 years; range, 53 to 82 years) with the diagnosis of peripheral artery disease between January 2017 and January 2020.
💡
Sonuç & Katkı:Conclusion: The perioperative and mid-term follow-up results of our study indicate that atherectomy and drug-coated balloon angioplasty may safely be performed by C-arm scopy with favorable outcomes.
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: This study aimed to present our results of endovascular procedures including balloon angioplasty combined with or without atherectomy for the treatment of iliofemoral and distal lesions with the use of a C-arm scopy. Patients and methods: The retrospective study was conducted on 153 patients (100 males, 53 females; mean age: 60.2±2.1 years; range, 53 to 82 years) with the diagnosis of peripheral artery disease between January 2017 and January 2020. The symptoms of the patients were claudication, rest pain, or tissue loss. The operations were performed at the operation theatre with local or spinal anesthesia in a supine or prone position according to the lesion status. Lesions were classified as superficial femoral, popliteal, and distal lesions below the knee. Results: Interventional treatment was applied in all patients, and 272 lesions in 204 extremities were intervened. In 78 patients, 160 right leg lesions were treated, and in 75 patients, a total of 112 lesions were treated. Fifty-one patients had bilateral leg lesions. The number of iliac, superficial femoral, and popliteal and distal segment lesions was 30 (11.1%), 213 (78.3%), and 29 (10.6%), respectively. Most of the lesions were confined to the SFA. We performed percutaneous transluminal angioplasty procedures in all 153 patients; however, 143 of them also received atherectomy with two different reliable devices (Avinger in 45 patients, Invamed in 114 patients). All interventions were done on a standard operating theatre bed with a C-arm scope. Doppler ultrasonography was used for popliteal imaging during the insertion. We did not encounter any problems in 125 patients. In 28 patients, progress was observed in the leg or ischemic wound between 30 and 65 postoperative days. A total of 23 patients required amputation; amputations were minor (finger amputation) in five patients and major (below the knee) in 18 patients. Conclusion: The perioperative and mid-term follow-up results of our study indicate that atherectomy and drug-coated balloon angioplasty may safely be performed by C-arm scopy with favorable outcomes.

🔖

Bu Makaleye Atıf Yap

ERDİNÇ, İ. (2022). Single center experience with percutaneous peripheral atherectomy with the use of C-arm scopy for the treatment of lower extremity peripheral artery disease İbrahim Erdinç. Cardiovascular surgery and interventions, Cilt: 9 - Sayı: 2, 111–120. https://ajindex.com/articles/470964

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Fowkes FG, Aboyans V, Fowkes FJ, McDermott MM, Sampson UK, Criqui MH. Peripheral artery disease: Epidemiology and global perspectives. Nat Rev Cardiol 2017;14:156-70
  2. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res 2015;116:1509-26
  3. Walsworth MK, de Bie R, Figoni SF, O'Connell JB. Peripheral artery disease: What you need to know. J Orthop Sports Phys Ther 2017;47:957-64
  4. Scully RE, Arnaoutakis DJ, DeBord Smith A, Semel M, Nguyen LL. Estimated annual health care expenditures in individuals with peripheral arterial disease. J Vasc Surg 2018;67:558-67
  5. Zeller T. Current state of endovascular treatment of femoropopliteal artery disease. Vasc Med 2007;12:223-34
  6. Kohn CG, Alberts MJ, Peacock WF, Bunz TJ, Coleman CI. Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample. Atherosclerosis 2019;286:142-6
  7. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013;382:1329-40
  8. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296
  9. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67
  10. Schepers A, Klinkert P, Vrancken Peeters MP, Breslau PJ. Complication registration in patients after peripheral arterial bypass surgery. Ann Vasc Surg 2003;17:198-202
  11. Mood G. Available at: https://www. hmpgloballearningnetwork.com/site/vdm/content/ atherectomy-treatment-lower-extremity-peripheral-arterydisease- critical-review [Accessed: December 03, 2021]
  12. Wiesinger B, Heller S, Schmehl J, Claussen CD, Wiskirchen J, Tepe G. Percutaneous vascular interventions in the superficial femoral artery. A review. Minerva Cardioangiol 2006;54:83-93
  13. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet 2005;366:1925-34
  14. McKinsey JF, Zeller T, Rocha-Singh KJ, Jaff MR, Garcia LA; DEFINITIVE LE Investigators. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITI